Drugs target to POLR3A

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
TAS-106Small moleculehead and neck malignant neoplasiaDNA-directed RNA polymerase III subunit RPC1 inhibitor2.0TerminatedClinicalTrials
TAS-106Small moleculecancerDNA-directed RNA polymerase III subunit RPC1 inhibitor1.0CompletedClinicalTrials